Managing an extension of screening intervals: Avoiding boom and bust in health care workloads

Author:

Pesola Francesca1,Rebolj Matejka1ORCID,Sasieni Peter1

Affiliation:

1. Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences Faculty of Life Sciences and Medicine, King's College London London UK

Abstract

AbstractExtending screening intervals in ongoing cancer screening programmes can lead to challenging year‐on‐year variations in the number of screening tests. We explored how such variation could be diminished with a managed transition to the extended interval. We defined three extension scenarios: immediate extension for the entire target population; stepped transition by birth cohort; and gradual transition by reducing the number of available screening appointments. These were compared to a situation in which the interval remains unchanged in a demographic model covering a 15‐year period. The model was populated with observed parameters from England, a real‐world setting recommending cervical screening with 3‐year intervals at age 25‐49 and 5‐year intervals at age 50‐64. Informed by typical changes currently considered by several European programmes including the programme in England, we explored the effect on screening test numbers of an extension of the 3‐year interval to 5 years for women younger than 50. All three extension scenarios resulted in similar cumulative numbers of screening tests, which were about 30% lower compared to a situation in which the interval would remain unchanged. However, the year‐on‐year variation in the number of screening tests varied between the scenarios. This variation was around 4‐fold for the immediate scenario. In the stepped scenario, the yearly numbers could differ by around 20%, whereas in the gradual scenario they were virtually constant. A managed interval extension, transitioning different groups of the target population at different times, can substantially reduce the yearly variation in screening workload without increasing the total number of screening tests in the long term.

Funder

Cancer Research UK

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

2. Public Health Wales.Cervical Screening Wales: Annual Statistical Reports 2014‐15 2015‐16 2016‐17 2017‐18 2018‐19.https://phw.nhs.wales/services-and-teams/cervical-screening-wales/information-resources/programme-reports/csw-annual-statistical-reports/. Accessed September 28 2022.

3. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans

4. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data;Rebolj M;BMJ,2022

5. U.K. National Screening Committee.Cervical Screening Programme Modifications Looking At; Interval/Surveillance Women Over 64 and Self‐Sampling; February 27 2019.https://legacyscreening.phe.org.uk/policydb_download.php?doc=1188. Accessed September 28 2022.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3